ImmuNovX Biotech Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

ImmuNovX Biotech General Information

Description

Operator of a deoxyribonucleic acid vaccine company intended to enable rapid, large-scale treatment of DNA pathogens. The company offers a cell-free manufacturing process that chemically binds the treated disease-causing agent, enabling pharmaceutical companies to develop a novel class of vaccines with reduced production time and costs.

Contact Information

Website
www.immunovx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bethlehem, PA
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Bethlehem, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuNovX Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 04-Jul-2026 Completed Startup
2. Accelerator/Incubator 19-Mar-2025 Completed Startup
1. Accelerator/Incubator 01-Jan-2024 Completed Startup
To view ImmuNovX Biotech’s complete valuation and funding history, request access »

ImmuNovX Biotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
Science Center Accelerator/Incubator
The Innovation Space Accelerator/Incubator
To view ImmuNovX Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial

ImmuNovX Biotech FAQs

  • Where is ImmuNovX Biotech headquartered?

    ImmuNovX Biotech is headquartered in Bethlehem, PA.

  • What industry is ImmuNovX Biotech in?

    ImmuNovX Biotech’s primary industry is Biotechnology.

  • Is ImmuNovX Biotech a private or public company?

    ImmuNovX Biotech is a Private company.

  • What is ImmuNovX Biotech’s current revenue?

    The current revenue for ImmuNovX Biotech is .

  • Who are ImmuNovX Biotech’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania, Science Center, and The Innovation Space have invested in ImmuNovX Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process